Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.940,99
0,22%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Scholar Rock Holdings Corporation (SRRK) Scholar Rock Holdings Corporation (SRRK) Notizie

SRRK

Scholar Rock (SRRK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRK
DataOraFonteTitoloSimboloCompagnia
24/06/202413:00Business WireScholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist WithdrawalNASDAQ:SRRKScholar Rock Holdings Corporation
18/06/202423:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
18/06/202422:15Business WireScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRRKScholar Rock Holdings Corporation
03/06/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRRKScholar Rock Holdings Corporation
03/06/202422:00Business WireScholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
28/05/202414:00Business WireScholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
22/05/202413:00Business WireScholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
20/05/202414:00Business WireScholar Rock to Participate in Upcoming Investor ConferencesNASDAQ:SRRKScholar Rock Holdings Corporation
14/05/202414:00Business WireScholar Rock to Host Investor Day on May 22, 2024NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202413:00Business WireScholar Rock Reports First Quarter 2024 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
19/03/202412:00Business WireScholar Rock Reports Full Year 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202422:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202414:00Business WireScholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific OfficerNASDAQ:SRRKScholar Rock Holdings Corporation
06/02/202414:00Business WireScholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss ManagementNASDAQ:SRRKScholar Rock Holdings Corporation
23/01/202415:02Dow Jones NewsScholar Rock Says FDA Clears Application for Trial of Obesity Treatment ApitegromabNASDAQ:SRRKScholar Rock Holdings Corporation
23/01/202414:00Business WireScholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
04/01/202414:00Business WireScholar Rock Provides Corporate Update and Highlights Priorities for 2024NASDAQ:SRRKScholar Rock Holdings Corporation
19/12/202314:00Business WireScholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
15/12/202300:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
07/11/202313:15Business WireScholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
03/11/202321:00Business WireScholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued TolerabilityNASDAQ:SRRKScholar Rock Holdings Corporation
19/10/202314:00Business WireScholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
16/10/202322:15Business WireScholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional SharesNASDAQ:SRRKScholar Rock Holdings Corporation
12/10/202322:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SRRKScholar Rock Holdings Corporation
12/10/202302:57Business WireScholar Rock Announces Pricing of Upsized Public Offering of Common StockNASDAQ:SRRKScholar Rock Holdings Corporation
11/10/202323:05Business WireScholar Rock Announces Proposed Public Offering of Common StockNASDAQ:SRRKScholar Rock Holdings Corporation
11/10/202322:44Business WireScholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic DisordersNASDAQ:SRRKScholar Rock Holdings Corporation
19/09/202314:00Business WireScholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE TrialNASDAQ:SRRKScholar Rock Holdings Corporation
09/08/202322:15Business WireScholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRK

La tua Cronologia

NYSE
JOBY
Joby Aviation
NYSE
BGY
BlackRock Enhanced Inter...
TG
BP46C4
BNP Paribas
TG
A1ZCRZ
European Investment Bank
BIBX
BLURUSDT
Blur
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network